Patents/Assignees

Beyondspring Phamaceuticals, Inc.

1 patent in portfolio

US12377094utility2025
Therapeutic Compositions and Methods for Treating Checkpoint Inhibitor-resistant Tumors Using Plinabulin-based Combination Therapies
0 cites